The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Booster inoculations of the AE37 peptide vaccine enhance immunological responses in a phase II study.
Eleftheria A Anastasopoulou
No relevant relationships to disclose
Efi Pappou
No relevant relationships to disclose
Panagiotis Tzonis
No relevant relationships to disclose
Alexandros Ardavanis
No relevant relationships to disclose
Sathibalan Ponniah
No relevant relationships to disclose
Constantin N. Baxevanis
No relevant relationships to disclose
James L. Murray
No relevant relationships to disclose
Michael Papamichail
No relevant relationships to disclose
Sonia A. Perez
No relevant relationships to disclose
George Earl Peoples
Consultant or Advisory Role - Generex Biotechnology
Research Funding - Generex Biotechnology
Elizabeth Ann Mittendorf
No relevant relationships to disclose